BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magistrelli L, Ferrari M, Furgiuele A, Milner AV, Contaldi E, Comi C, Cosentino M, Marino F. Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives. Int J Mol Sci 2021;22:3781. [PMID: 33917417 DOI: 10.3390/ijms22073781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chand J, Subramanian G, Jupudi S, Duyu T, Baba MZ, Wahedi U. Neuroprotective Effect of Scutellaria baicalensis in Parkinson’s disease and Multi-Target Mechanisms Based on Network Pharmacology.. [DOI: 10.21203/rs.3.rs-2217744/v1] [Reference Citation Analysis]
2 Angelopoulou E, Bougea A, Papageorgiou SG, Villa C. Psychosis in Parkinson's Disease: A Lesson from Genetics. Genes (Basel) 2022;13:1099. [PMID: 35741861 DOI: 10.3390/genes13061099] [Reference Citation Analysis]
3 Terkelsen MH, Klaestrup IH, Hvingelby V, Lauritsen J, Pavese N, Romero-Ramos M. Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies. J Parkinsons Dis 2022. [PMID: 35723115 DOI: 10.3233/JPD-223245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chang HY, Li YY, Hong CT, Kuan YC. Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2022;:2698811221093795. [PMID: 35546511 DOI: 10.1177/02698811221093795] [Reference Citation Analysis]
5 Pelzer EA, Stürmer S, Feis D, Melzer C, Schwartz F, Scharge M, Eggers C, Tittgemeyer M, Timmermann L. Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09657-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Parnham MJ, Kricker JA. Factors Determining Plasticity of Responses to Drugs. IJMS 2022;23:2068. [DOI: 10.3390/ijms23042068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fedosova A, Titova N, Kokaeva Z, Shipilova N, Katunina E, Klimov E. Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy. J Pers Med 2021;11:1321. [PMID: 34945793 DOI: 10.3390/jpm11121321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dogra N, Nagpal D, Aeri V, Ahmad S, Pande Katare D. Evaluating the synergistic effect of Mucuna prurines extract and sesame oil against the Parkinson’s disease zebrafish model: in-vivo / in-silico approach. All Life 2021;14:1022-42. [DOI: 10.1080/26895293.2021.1994472] [Reference Citation Analysis]
9 Lavezzi AM. Altered Development of Mesencephalic Dopaminergic Neurons in SIDS: New Insights into Understanding Sudden Infant Death Pathogenesis. Biomedicines 2021;9:1534. [PMID: 34829763 DOI: 10.3390/biomedicines9111534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]